Safety Testing

Data and Instruments

Data from Medpace central laboratories has been key for assessing the safety, tolerability, and efficacy of new drugs in development. With the increasing complexity and global scale of many clinical trials, it is important to maintain testing harmonization among each Medpace laboratory. In order to ensure that all results generated globally are harmonized, Medpace labs has an extensive inter-laboratory comparison program.  This ensures lab data reflects the impact of a compound and not differences in testing practices.  The program is performed weekly at each Medpace laboratory to provide continual monitoring of global consistency. Ten split samples are analyzed weekly on the same day in all Medpace labs globally for analytes across all major platforms. Additional assays can be added to monitor testing specific to a clinical program. Medpace utilizes global standard operating procedures, and identical assay platforms, calibrators, and quality control material.

Key Instrumentation

Chemistry and Immunoassays

Medpace’s central laboratories offer highly automated, state of the art chemistry and immunoassay analyzers to support safety testing, serology, drug screening, and biomarker testing for all phases of pharmaceutical trials.

Central Lab Services

Key Instrumentation

Urinalysis / Drug Screening / Urine Biomarkers

Urine testing is a part of Medpace’s safety testing and biomarker services. New urine biomarkers are continually being added to the test menu.

Urine Safety Tests

Urine Biomarkers